T-Cell Subsets in Rheumatoid Arthritis Patients on Long-Term Anti-TNF or IL-6 Receptor Blocker Therapy

Figure 2

Proportions of various T-cell subsets in rheumatoid arthritis patient groups of anti-TNF responders (), anti-TNF nonresponders (), and IL-6R blocker responders (), early, active, therapy-naïve RA patients (), and healthy controls (). Data are presented as median (horizontal line within boxes), 25 and 75 percentile (horizontal borders of the boxes), and minimum and maximum (whiskers). ^A versus anti-TNF responder, ^B versus anti-TNF nonresponder, ^C versus IL-6R blocker responder, ^D versus early, untreated RA patients.